Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Pharmacogenetics and Atorvastatin Interaction
NCT01112670Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sitagliptin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by University of Colorado Denver. Primary endpoints: Sitagliptin Area Under the Plasma Concentration-time Curve (AUC) From 0 to Infinity, Sitagliptin Maximum Plasma Concentration and 1 more. Started Nov 2009; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01112670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01112670.